Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Increased NLRP3 Inflammasome Activation and Pyroptosis in Patients With Multiple Sclerosis With Fingolimod Treatment Failure
Sunny Malhotra, Laura Hurtado‐Navarro, Agustín Pappolla, et al.
Neurology Neuroimmunology & Neuroinflammation (2023) Vol. 10, Iss. 3
Open Access | Times Cited: 13

Showing 13 citing articles:

NLRP3 inflammasome and its role in autoimmune diseases: A promising therapeutic target
Wenxuan Ren, Ying Sun, Lei Zhao, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116679-116679
Open Access | Times Cited: 9
The impact of aging and oxidative stress in metabolic and nervous system disorders: programmed cell death and molecular signal transduction crosstalk
Kenneth Maiese
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 20
Fingolimod Suppresses NLRP3 Inflammasome Activation and Alleviates Oxidative Stress in Traumatic Brain Injury-Induced Acute Lung Injury
Qi Shi, Tingting Hu, Lixia Xu, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 2229-2245
Open Access
Cognitive Impairment in Multiple Sclerosis
Kenneth Maiese
Bioengineering (2023) Vol. 10, Iss. 7, pp. 871-871
Open Access | Times Cited: 11
Cornerstone Cellular Pathways for Metabolic Disorders and Diabetes Mellitus: Non-Coding RNAs, Wnt Signaling, and AMPK
Kenneth Maiese
Cells (2023) Vol. 12, Iss. 22, pp. 2595-2595
Open Access | Times Cited: 11
Microglial NLRP3 inflammasome-mediated neuroinflammation and therapeutic strategies in depression
Qiu-Qin Han, Wenhui Li, Peiqing Chen, et al.
Neural Regeneration Research (2023) Vol. 19, Iss. 9, pp. 1890-1898
Open Access | Times Cited: 9
Emerging role of galectin 3 in neuroinflammation and neurodegeneration
Brian M. Lozinski, Khanh Ta, Yifei Dong
Neural Regeneration Research (2023) Vol. 19, Iss. 9, pp. 2004-2009
Open Access | Times Cited: 8
Detection of serum interleukin-18 level and neutrophil/lymphocyte ratio in patients with antineutrophil cytoplasmic antibody-associated vasculitis and its clinical significance
Changning Liu
Open Life Sciences (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 2
Inflammasomes in neurodegenerative diseases
Qianchen Wang, Songwei Yang, Xuan Zhang, et al.
Translational Neurodegeneration (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Flow Cytometry: A Versatile and Powerful Tool for Drug Discovery and Development
Başak Aru, Gülderen Yanıkkaya Demirel
Pharmedicine journal. (2024) Vol. 1, Iss. 1, pp. 1-19
Open Access
Multiple sclerosis: the NLRP3 inflammasome, gasdermin D, and therapeutics
Amie Brint, Seth Greene, Alyssa R Fennig-Victor, et al.
Annals of Translational Medicine (2024) Vol. 12, Iss. 4, pp. 62-62
Open Access
Pyroptosis the Emerging Link Between Gut Microbiota and Multiple Sclerosis
Hua Fan, Ruile Shen, Junqiang Yan, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 6145-6164
Open Access
Clinical Depression, the Mechanistic Target of Rapamycin (mTOR), and Forkhead Transcription Factors (FoxOs)
Kenneth Maiese
Current Neurovascular Research (2023) Vol. 20, Iss. 4, pp. 429-433
Closed Access
Page 1

Scroll to top